Conflict of Interest: None
Migraine Does Not Affect Cognitive Decline: Results From the Maastricht Aging Study
Article first published online: 17 NOV 2009
© 2009 the Authors. Journal compilation © 2009 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 50, Issue 2, pages 176–184, February 2010
How to Cite
Baars, M. A.E., Van Boxtel, M. P.J. and Jolles, J. (2010), Migraine Does Not Affect Cognitive Decline: Results From the Maastricht Aging Study. Headache: The Journal of Head and Face Pain, 50: 176–184. doi: 10.1111/j.1526-4610.2009.01572.x
- Issue published online: 24 JAN 2010
- Article first published online: 17 NOV 2009
- Accepted for publication September 6, 2009.
- cognitive performance decline;
- medication use;
- executive functioning
Objective.— To investigate the effects of migraine and related pharmacotherapy on cognitive performance and cognitive change over time in a longitudinal population-based study.
Methods.— Migraineurs (n = 99) and healthy controls (n = 1724) participating in the Maastricht Aging Study were cognitively tested at baseline and after 6 years. Scores on Mini Mental State Examination, immediate and delayed recall tests, and tests for simple and complex speed were compared for both groups. Generalized Estimating Equations analyses were performed to test the longitudinal effects of migraines on cognition. Effects of migraine medication use were also tested.
Results.— Migraine headaches were found to have no effect on any of the cognitive measures. Medication use also had no effect on all cognitive measures.
Conclusions.— No evidence was found that migraine headaches or migraine-related medication use are risk or protective factors for cognitive dysfunction or cognitive deterioration over time.